Generated by Meeveem AI
"Leading CDMO and CRO accelerating biologics and bioconjugates from discovery to commercial launch"
Abzena provides integrated contract research, development, and manufacturing for complex biologics and bioconjugates, including antibody drug conjugates. With facilities across the United States and United Kingdom, the company delivers end to end support from discovery through commercial manufacturing. Over 20 years of expertise and proprietary technologies enable Abzena to tackle challenging programs other providers often avoid. Pharmaceutical and biotech companies partner with Abzena to accelerate timelines, reduce risk, and bring treatments to patients faster. Interconnected teams work across discovery, analytics, and GMP manufacturing, ensuring seamless transitions and proactive problem solving throughout the development lifecycle.
430
Team Members
2001
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where innovative medicines reach patients faster through integrated scientific expertise and seamless development pathways.
Abzena helps pharmaceutical and biotech companies bring their treatments to market, delivering on our mission to move medicine forward.